First Wave BioPharma Inc. Gains 50.27%
Wed, Dec 27, 2023 at 11:31 PM
First Wave BioPharma Inc. (FWBI:NASDAQ) soared at $5.53, a gain of 50.3%. On Wed, Dec 27, 2023, FWBI:NASDAQ hit a New 2-Week High of $5.53. The stock appeared on our News Catalysts scanner on Wed, Dec 27, 2023 at 03:11 PM in the 'PRIVATE PLACEMENT' category. From Thu, Dec 14, 2023, the stock recorded 50.00% Up Days and 33.33% Green Days
The stock spiked on Wed, Dec 27, 2023 at $14.5 with a volume of 26M+.
About First Wave BioPharma Inc. (FWBI:NASDAQ)
First Wave BioPharma Inc is a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal diseases.
Top 10 Gainers:
- Oncorus Inc. (ONCR:NASDAQ), 669.23%
- Esports Technologies Inc. (EBET:NASDAQ), 244.43%
- RiskOn International Inc Com Par $0.001 (ROI:NASDAQ), 205.4%
- Republic First Bancorp, Inc. (FRBK:NASDAQ), 110.74%
- Cingulate Inc. (CING:NASDAQ), 90.91%
- Cytokinetics, Incorporated (CYTK:NASDAQ), 82.54%
- Earlyworks Co. Ltd. (ELWS:NASDAQ), 69.31%
- Erayak Power Solution Group Inc. (RAYA:NASDAQ), 50.73%
- First Wave BioPharma Inc. (FWBI:NASDAQ), 50.27%
- Vince Holding Corp. (VNCE:NYSE), 48.68%